HOME >> MEDICINE >> NEWS
Study shows Actonel reduces vertebral fracture risk 70 percent in patients on chronic steroid therapy

Las Vegas Vertebral fracture risk in men and women who take oral glucocorticoid treatment (> 7.5 mg/day prednisone or equivalent) for chronic diseases is significantly reduced with Actonel (risedronate sodium tablets) 5 mg in just one year, according to data presented today at the 66th Annual Scientific Meeting of the American College of Gastroenterology in Las Vegas.

Patients on Actonel 5 mg daily while initiating or continuing glucocorticoid (a class of steroids) therapy experienced significant vertebral fracture reduction of 70 percent compared to placebo (p=0.01, absolute risk reduction 10.8 percent) within just one year. All patients received calcium supplementation and some received vitamin D. Vertebral fractures were confirmed radiographically, some were associated with symptoms.

The research results were presented by Stanley Wallach, M.D., Executive Director of the American College of Nutrition and Co-Director of the Hospital for Joint Diseases Osteoporosis Center at ArthroFitness, New York, N.Y., involving over 500 men and women, age 18 to 85, on chronic glucocorticoid therapy.

The majority of patients on chronic glucocorticoid therapy do not receive treatment to prevent bone loss, said Dr. Wallach. Early intervention is important because glucocorticoid-induced bone loss can happen in as little as three months, which can quickly lead to fractures.

It is estimated that up to 50 percent of patients on chronic glucocorticoid therapy (> 7.5 mg/day prednisone or equivalent) will experience osteoporotic fractures. Glucocorticoids are a primary therapy for many inflammatory and autoimmune diseases including asthma and rheumatoid arthritis as well as many allergic conditions.

Guidelines issued earlier this year by the ACR recommend bisphosphonates as first-line therapy for preventing GIO in men and postmenopausal women. This is in conjunction with calcium, vitamin D and lifestyle modifications for patients who are initiatin
'"/>

Contact: Jim Guarnera
jguarner@hillandknowlton.com
212-885-0303
Hill and Knowlton
24-Oct-2001


Page: 1 2 3 4 5

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... 19, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... statutory advisor to the U.S. Department of Health and Human Services (HHS), today issued ... was issued following the release last week at the HIMSS Global Conference and Exhibition ...
(Date:2/19/2019)... ... 2019 , ... In one of the first research studies ... team led by a Worcester Polytechnic Institute professor found that women who experience ... weight gain during pregnancy, and weight retention after their baby is born. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Alejandro ... patients with or without a referral who are interested in full arch permanent ... Kovacs routinely places All-on-4® dental implants in Texarkana, TX, for those ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... opioid epidemic with town halls across the country , A partnership between Liberty ... nationwide opioid crisis, continues with its next town hall event on Tuesday, February ...
(Date:2/19/2019)... ... February 19, 2019 , ... Catalent ... solutions for drugs, biologics and consumer health products, today announced that Michael ... Bioassay Conference of the BioPharmaceutical Emerging Best Practices Association (BEBPA), taking place ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... , ... February 19, 2019 , ... ... cure for Job Syndrome by providing the scientific community with additional opportunities to ... Alain Fischer as Chief Scientific Officer of the Foundation’s Scientific Advisory Board and ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... RCH ... firms of all sizes, announces the hiring of Frank Iafrato as Director of Sales ... to deepen the firm’s sales coverage throughout the Northeast region, building upon the momentum ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... for gum disease that utilizes modern dental lasers. The Laser Assisted New Attachment ... bacteria and diseased tissue, the leading cause of gum disease. Dr. Farahmand is ...
Breaking Medicine Technology:
Cached News: